A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: A UK perspective

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue SUPPL. 1, 2006, Pages 447-451

  Spoudeas, Helen A ^a   Saran, Frank ^b   Pizer, Barry ^c  

^a London Centre for Paediatric Endocrinology   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; DOXORUBICIN; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADIPSIA; ARTICLE; BEHAVIOR DISORDER; BRAIN INJURY; CANCER RECURRENCE; CHILD; CHILDHOOD CANCER; COGNITIVE DEFECT; CONSERVATIVE TREATMENT; CRANIOPHARYNGIOMA; ENDOCRINE FUNCTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS LESION; MAJOR CLINICAL STUDY; MORBIDITY; NEUROTOXICITY; OBESITY; RADIATION HAZARD; RECURRENCE RISK; REOPERATION; RISK ASSESSMENT; RISK REDUCTION; SCLEROTHERAPY; SLEEP DISORDER; STEREOTAXIC SURGERY; SURGICAL APPROACH; SURGICAL MORTALITY; TREATMENT OUTCOME; TUMOR VOLUME; UNITED KINGDOM; VISION; VISUAL IMPAIRMENT;

COMBINED MODALITY THERAPY; CRANIOPHARYNGIOMA; HUMANS; HYPOTHALAMIC DISEASES; PITUITARY NEOPLASMS; RISK ASSESSMENT;

EID: 33646168281     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurol Clin 1991; 9: 453-465.
2. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1996; 89: 547-551.
3. De Vile C, Grant DB, Kendall BE, Neville BGR, Stanhope R, Watkins KE, Hayward RD. Management of childhood craniopharyngioma: Can the morbidity of radical surgery be predicted? J Neurosurg 1996; 85: 73-81.
4. Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E. Outcome of craniopharyngioma in children: long term complications and quality of life. Dev Med Child Neurol 2004; 46: 220-229.
5. Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992; 76: 47-52.
6. Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas: approaches and long-term results in 144 patients. J Neurosurg 1990; 73: 3-11.
7. De Vile CJ, Grant DB, Hayward RD, Stanhope R Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996; 75: 108-114.
8. Hayward RD, De Vile C, Brada M. Craniopharyngioma. In: Walker DA, Perilongo G, Punt JAG, Taylor RE, eds. Brain and Spinal Tumors of Childhood. New York: Arnold, 2004; 370-386.
9. Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 2002; 4: 1114-1120.
10. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D. The long term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 1993; 38: 571-578.
11. Habrand JL, Ganry O, Couanet D, Rouxel V, Levy-Piedbois C, Pierre-Kahn A, Kalifa C. The role of radiation therapy in the management of craniopharyngioma: a 25 year experience and review of the literature. Int J Radiat Oncol Biol Phys 1999; 44: 255-263.
12. De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R. Hyperphagia and obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 1996; 81: 2734-2737.
13. Van Effenterre V, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 2002; 97: 3-11.
14. Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 1999; 90: 251-257.
15. Bin-Abbas B, Horia Mawlawi, H, Sakati N, Khajafa Y, Chadhary MA, Al-Ashwal A. Endocrine sequelae of childhood craniopharyngioma, J Pediatr Endocrinol Metab 2001; 14: 869-874.
16. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999; 90: 237-250.
17. De Vile CJ. A follow-up study of the outcome of children post-craniopharyngioma surgery. M.D. Thesis, University of London, 1998.
18. Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ. 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 1993; 27: 189-195.
19. Sklar CA. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 1994; 21 (Suppl 1): 18-20.
20. Rajan B, Ashley S, Groman C, Jose CC, Horwich A, Bloom HJG, Marsh H, Brada M. Craniopharyngioma: long term results following limited surgery and radiotherapy. Radiother Oncol 1993; 26: 1-10.
21. Stripp DCH, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN. Surgery with or without radiation therapy in children and young adults. Int J Radiat Oncol Biol Phys 2004; 58: 714-720.
22. Brada M, Thomas DGT. Craniopharyngioma revisited. Int J Radiat Oncol Biol Phys 1993; 27: 471-475.
23. Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 2002; 53: 533-542.
24. Hoffman HJ. Surgical management of craniopharyngioma. Pediatr Neurosurg 1994; 21 (Suppl 1): 44-49.
25. Carpentieri SC, Waber DP, Scott M, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL. Memory deficits among children with craniopharyngiomas. Neurosurgery 2001; 49: 1053-1057.
26. Cavazzuti V, Fischer EG, Welch K, Belli JA, Winston KR. Neurological and psycho-pathological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 1983; 59: 409-417.
27. Mulhern RE, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5: 399-408.
28. Bremer AM, Nguyen TQ, Balsys R. Therapeutic benefits of combination chemotherapy with vincristine, BCNU and procarbazine on recurrent cystic craniopharyngioma. J Neurooncol 1984; 2: 47-51.
29. Lippens RJJ Rotteveel JJ, Otten BJ, Merx H. Chemotherapy with adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma. Eur J Pediatr Neurol 1998; 2: 263-268.
30. Voges J, Sturn V, Lehrke R, Treuer H, Gauss C, Berthold F. Cystic craniopharyngioma: long term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 1997; 40: 263-270.
31. Jiang R, Liu Z, Zhu C. Preliminary exploration of the clinical effect of bleomycin on craniopharyngiomas. Stereotact Funct Neurosurg 2002; 78: 84-94.
32. Hader WJ, Steinbok P, Hukin J, Fryer C. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 2000; 33: 211-218.
33. Mottolese C, Stan H, Hermier M, Berlier P, Convert J, Frappaz D, Lapras C. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv System 2001; 17; 724-730.
34. Park DH, Park JY, Chung YG, Lee HK, Lee KC, Suh JK. Outcome of postoperative intra tumoral bleomycin injection in cystic craniopharyngioma. J Korean Med Sci 2002; 17: 254-259.
35. Lunsford LD, Pollock BE, Kondziolka DS, Levine G, Flickinger JC. Stereotactic options in the management of craniopharyngioma. Pediatr Neurosurg 1994; 21 (Suppl 1): 90-97.
36. Kobayashi T, Tanaka T, Kida Y. Stereotactic gamma radiosurgery of craniopharyngiomas. Pediatr Neurosurg 1994; 21: 69-74.
37. Jackson IM, Noren G. Gamma knife radiotherapy for pituitary tumours. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13: 461-469.
38. Reda WA, Hay AA, Ganz JC. A planned stereotactic approach for cystic intracranial tumours. Report of two cases. J Neurosurg 2002; 97 (Suppl): 610-612.